More importantly, in vivo studies demonstrated that adult and JDM patients exhibit higher IL-6 levels compared to healthy controls, and IL-6 levels correlate with disease activity and an IFN-I signature (55–57). This evidence concerns the gene IL6 and juvenile dermatomyositis.